Public Release Summary on bromethalin in Fastrac G Blox Rodenticide and associated secondary products

This consultation closed on 2 July 2021.
Consultation period: 
4 June 2021 to 2 July 2021

The Australian Pesticides and Veterinary Medicines Authority (APVMA) is considering an application for approval of the new active constituent bromethalin and registration of the products Fastrac G Blox Rodenticide, Fastrac Pro Blox Rodenticide, Fastrac G Place Pacs Rodenticide, Fastrac G Pellets Rodenticide, Fastrac Pro Place Pacs Rodenticide, Fastrac Pro Pellets Rodenticide, Fastrac G Meal Bait Rodenticide, and Fastrac Pro Soft Bait Rodenticide.

We invite comment from 4 June 2021 to 2 July 2021 on whether approval of the active constituent and registration of the products should be granted.

The APVMA is able to consider comments relating to the legislative basis, including:

  • chemistry and manufacture
  • public health
  • occupational health and safety
  • residues in food
  • trade
  • environmental safety
  • efficacy and target crop safety.

Download the Public Release Summary on the evaluation of bromethalin and the associated products.

For more information see the APVMA Special Gazette, 4 June 2021.

Please note: Submissions will be published on the APVMA’s website, unless you have asked for the submission to remain confidential (see public submission coversheet).

Please lodge your submission with a public submission coversheet, which provides options for how your submission will be published.

Note that all APVMA documents are subject to the access provisions of the Freedom of Information Act 1982 and may be required to be released under that Act should a request for access be made.

Please send your written submission and coversheet by email or post to:

Email: enquiries@apvma.gov.au

Post:

Executive Director, Registration Management
Australian Pesticides and Veterinary Medicines Authority
GPO Box 3262
Sydney NSW 2001

Your feedback will be submitted to the APVMA anonymously. If you require a response, please contact us.